Ignite Creation Date:
2025-12-24 @ 4:16 PM
Ignite Modification Date:
2025-12-24 @ 4:16 PM
Study NCT ID:
NCT04200066
Status:
WITHDRAWN
Last Update Posted:
2022-08-22
First Post:
2019-12-05
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
Sponsor:
University of Rochester
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-10-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-05
First Submit QC Date:
None
Study First Post Date:
2019-12-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-17
Last Update Post Date:
2022-08-22
Last Update Post Date Type:
ACTUAL